95 results
Page 2 of 5
PRE 14A
0lbswr29 t3u
4 Apr 22
Preliminary proxy
4:15pm
424B5
kjn7yt1i9 ixuymyb
2 Mar 22
Prospectus supplement for primary offering
8:24am
8-K
EX-99.1
yh9h9sxonh2zipahgpr
11 Jan 22
Invitae Reports Preliminary 2021 Revenue of More Than $458 Million and Billable Volume of More Than 1.16 Million
4:20pm
8-K
EX-99.2
07xzet5bo61zvhg
7 Sep 21
Invitae to Acquire Ciitizen to Strengthen its Patient-Consented Health Data Platform to Improve Personal Outcomes and Global Research
8:01am
8-K
EX-99.1
9zq0j
7 Sep 21
Invitae to Acquire Ciitizen to Strengthen its Patient-Consented Health Data Platform to Improve Personal Outcomes and Global Research
8:01am
424B5
p09x o0jg9d8
4 May 21
Prospectus supplement for primary offering
5:10pm
8-K
EX-99.1
lijsqz
17 Feb 21
Invitae Reports $279.6 Million in Annual Revenue Driven by 659,000 in Billable Volume in 2020
4:09pm
424B5
ekqerqw1ed urt
25 Jan 21
Prospectus supplement for primary offering
4:02pm
424B5
xizuqksuu d83nz
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K
EX-99.2
xztgfd30
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
g8tgzbp1kyek0bghc
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
EX-99.2
kk115 ozpirid
12 Jan 21
Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable Volume
6:06am
8-K/A
EX-99.2
oy5u8alcbjnd6gf9x
23 Nov 20
Consolidated Financial Statements
12:00am
424B3
1ihm79thxc4
28 Aug 20
Prospectus supplement
4:31pm